Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P K Honig

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Clinical Pharmacology and Therapeutics|May 22, 2013
Advancing the science of pharmacovigilanceP K Honig
Clinical Pharmacology and Therapeutics|February 25, 2011
Prevalence and clinical utilityP K Honig
Clinical Pharmacology and Therapeutics|April 22, 2014
Recent trends and success factors in reducing the lag time to approval of new drugs in JapanP K Honig
Clinical Pharmacology and Therapeutics|January 22, 2011
Comparative effectiveness: the fourth hurdle in drug development and a role for clinical pharmacologyP K Honig
Clinical Pharmacology and Therapeutics|February 21, 2012
The right medicines--just not enough of themP K Honig
Clinical Pharmacology and Therapeutics|February 19, 2009
Drug safety and the role of clinical pharmacology in the safe use of therapeuticsP K Honig
Clinical Pharmacology and Therapeutics|July 22, 2010
Systematic reviews and meta-analyses in the new age of transparencyP K Honig
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacotherapy for Neurodegenerative Diseases: Are We Approaching the Tipping Point?P K Honig
Clinical Pharmacology and Therapeutics|November 19, 2016
Adaptive Biomedical InnovationP K Honig, G Hirsch
Clinical Pharmacology and Therapeutics|February 21, 2012
Regulatory science and the role of the regulator in biomedical innovationP K Honig, S-M Huang
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|May 22, 2013
Advancing the science of pharmacovigilanceP K Honig
Clinical Pharmacology and Therapeutics|February 25, 2011
Prevalence and clinical utilityP K Honig
Clinical Pharmacology and Therapeutics|April 22, 2014
Recent trends and success factors in reducing the lag time to approval of new drugs in JapanP K Honig
Clinical Pharmacology and Therapeutics|January 22, 2011
Comparative effectiveness: the fourth hurdle in drug development and a role for clinical pharmacologyP K Honig
Clinical Pharmacology and Therapeutics|February 21, 2012
The right medicines--just not enough of themP K Honig
Clinical Pharmacology and Therapeutics|February 19, 2009
Drug safety and the role of clinical pharmacology in the safe use of therapeuticsP K Honig
Clinical Pharmacology and Therapeutics|July 22, 2010
Systematic reviews and meta-analyses in the new age of transparencyP K Honig
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacotherapy for Neurodegenerative Diseases: Are We Approaching the Tipping Point?P K Honig
Clinical Pharmacology and Therapeutics|November 19, 2016
Adaptive Biomedical InnovationP K Honig, G Hirsch
Clinical Pharmacology and Therapeutics|February 21, 2012
Regulatory science and the role of the regulator in biomedical innovationP K Honig, S-M Huang
Pageof 4